Home · Health · Oct 22 archive
Kennedy’s Vaccine Plan Could Cause Surge in Hepatitis B, Study Finds
Confirmed
In Short: No journal article matching this report (Kennedy’s Vaccine Plan Could Cause Surge in Hepatitis B, Study Finds) was found in the research index, and no page published by the researchers turned up in the search.
A study published in Time suggests that delaying the first dose of the hepatitis B vaccine until two months after birth could lead to a substantial increase in chronic infections among infants.
According to the research, if only about 26% of children are vaccinated under a shared decision-making scenario, chronic hepatitis B cases could rise by 225%.
The study modeled various scenarios involving 3.6 million children born in the same year in the U.S., including the impact of delaying the initial dose.
The researchers found that delaying the first dose until two months of age and vaccinating only 75% of infants could result in a 19% increase in chronic cases compared to vaccinating all children at birth.
Early-in-life hepatitis B infections, if left untreated, carry a 1 in 4 lifetime chance of developing liver cancer.
The American Association of Pediatrics continues to recommend vaccination at birth against hepatitis B for all infants, and 15 states have sued the Trump Administration over changes to the vaccination schedule.
The CDC has historically recommended that all infants receive a hepatitis B vaccine dose within 24 hours of birth.
The hepatitis B vaccine given shortly after birth serves two purposes: it protects an infant who may already face a known exposure risk, and it provides a safety net when that risk has not been identified.
Infants born to mothers who test positive for hepatitis B or whose infection status is unknown should still receive the hepatitis B vaccine and hepatitis B immune globulin (HBIG) within 12 hours of birth, according to updated guidelines.
Hepatitis B is a liver infection caused by the hepatitis B virus, and a person can carry the virus without obvious symptoms.
Among babies infected before they turn one, up to 90% develop a chronic, potentially lifelong infection, for which there are treatments but no cure.
No journal article matching this report (Kennedy’s Vaccine Plan Could Cause Surge in Hepatitis B, Study Finds) was found in the research index, and no page published by the researchers turned up in the search.
Background
A new study published in Nature Medicine finds menopause causes sudden changes in bone density, liver function, and blood fats, challenging previous assumptions.
Researchers found that menopause triggers sudden shifts in bone density, liver function, and blood fats, challenging previous assumptions.
What's confirmed
- A study published in Time suggests that delaying the first dose of the hepatitis B vaccine until two months after birth could lead to a substantial increase in chronic infections among infants.
- According to the research, if only about 26% of children are vaccinated under a shared decision-making scenario, chronic hepatitis B cases could rise by 225%.
- The study modeled various scenarios involving 3.6 million children born in the same year in the U.S., including the impact of delaying the initial dose.
- The researchers found that delaying the first dose until two months of age and vaccinating only 75% of infants could result in a 19% increase in chronic cases compared to vaccinating all children at birth.
- Early-in-life hepatitis B infections, if left untreated, carry a 1 in 4 lifetime chance of developing liver cancer.
- The American Association of Pediatrics continues to recommend vaccination at birth against hepatitis B for all infants, and 15 states have sued the Trump Administration over changes to the vaccination schedule.
- The CDC has historically recommended that all infants receive a hepatitis B vaccine dose within 24 hours of birth.
- The hepatitis B vaccine given shortly after birth serves two purposes: it protects an infant who may already face a known exposure risk, and it provides a safety net when that risk has not been identified.
- Infants born to mothers who test positive for hepatitis B or whose infection status is unknown should still receive the hepatitis B vaccine and hepatitis B immune globulin (HBIG) within 12 hours of birth, according to updated guidelines.
- Hepatitis B is a liver infection caused by the hepatitis B virus, and a person can carry the virus without obvious symptoms.
- Among babies infected before they turn one, up to 90% develop a chronic, potentially lifelong infection, for which there are treatments but no cure.
- No journal article matching this report (Kennedy’s Vaccine Plan Could Cause Surge in Hepatitis B, Study Finds) was found in the research index, and no page published by the researchers turned up in the search.
What's still developing
- A news rewrite is not the researchers' measurement.
- The paper "Poor uptake of hepatitis B vaccine in India has several causes, study finds". was published in BMJ in 2013. The authors are C. Travasso. DOI 10.1136/bmj.f3596.
- Another, looking at the economic ramifications, found that even if every child eventually received the vaccine, delaying the first dose by 2 months yielded an additional $16.4 million in health care spending on new infections.
- Follow this section to personalize your feed and get instant alerts.
- Source 9 Understanding the controversy requires separating four things: a scientific study, a policy proposal, an ACIP recommendation, and final guidance adopted by the Centers for Disease Control and Prevention.
- Kennedy’s influence over vaccine policy has grown amid broader political disputes about immunization recommendations, according to STAT.
- The warnings concern a possible shift from broadly recommending the hepatitis B birth dose to a targeted approach for infants considered at higher risk.
- Source 1 The projected increase does not show that a nationwide surge has already occurred.
- CDC The policy debate concerns whether the hepatitis B vaccine should remain broadly recommended for newborns or be targeted primarily at infants with an identified risk.
- She is also a yoga and mindfulness teacher and the co-author of “ The Yoga Almanac.” Connect with her on LinkedIn, email her with story tips and pitches, and find her at her website.
- “Hepatitis B immunizations have been proven to protect individuals against a serious and significant disease,” said Graham Tse, MD, pediatrician and chief medical officer of MemorialCare Miller Children’s & Women’s Hospital in Long Beach, CA.
- “We have actual world evidence that vaccinating newborns for hepatitis B prevents hepatitis B infections later in life and the serious complications of that disease,” Tse said.